Phentermine vs GLP-1 comparisons reveal significant differences in safety, efficacy, and duration of use
Contraindications include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, and severe gastroparesis
Given the popularity of and rapid rise in the use of this class of receptor agonists, the need for this guidance has become increasingly urgent
Graphical abstract Similar content being viewed by others Introduction The incretin-based drug classes, dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists, are commonly used for treatment of type 2 diabetes
Kit Items Compare the closest options in the same product family before you choose
Kidney Int 1999;69:93-106